MedTrace Logo

Science-Based Treatment for Opioid-Dependent Adolescents

NCT00182572 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-08-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate ways to optimize outcomes from combined behavioral-pharmacological treatment for opioid-dependent youth.

Conditions

  • Opioid-Dependence Among Adolescents

Interventions

DRUG

buprenorphine

DRUG

naltrexone

PROCEDURE

behavior therapy

PROCEDURE

voucher-based contingency management

Sponsors & Collaborators

  • St. Luke's-Roosevelt Hospital Center

    collaborator OTHER

  • National Development and Research Institutes, Inc.

    lead OTHER

Principal Investigators

  • Lisa Marsch, PhD · National Development and Research Institutes, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182572 on ClinicalTrials.gov